{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:52:54Z","timestamp":1788457974033,"version":"build-2803163510"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/mpa.0b013e3181ec1261","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T11:10:36Z","timestamp":1279710636000},"page":"767-774","source":"Crossref","is-referenced-by-count":248,"title":["The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs)"],"prefix":"10.1097","volume":"39","author":[{"given":"Lowell B.","family":"Anthony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Strosberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Maples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"O'Dorisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.P.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al B.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney F.","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210212","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1200\/JCO.2008.16.7858","article-title":"Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study. Erratum appears in J Clin Oncol. 2008;26(34):5660..","volume":"1926","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"R2-6-20210212","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11605-007-0153-8","article-title":"Viability of endoscopic and excisional treatment of early rectal carcinoids.","volume":"11","author":"Merg","year":"2007","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"R3-6-20210212","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.mog.0000239868.27328.1d","article-title":"Rectal carcinoids. Review 45 refs.","volume":"22","author":"Wang","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"R4-6-20210212","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors.","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"R5-6-20210212","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1309\/AJCP9H1OTMUCSKQW","article-title":"Neuroendocrine carcinomas of the lung: a critical analysis.","volume":"131","author":"Moran","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"R6-6-20210212","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1309\/TGCD66L31DHYX5HK","article-title":"Immunohistochemical staining of cytologic smears with MIB-1 helps distinguish low-grade from high-grade neuroendocrine neoplasms.","volume":"120","author":"Lin","year":"2003","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"R7-6-20210212","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.pas.0000149690.75462.29","article-title":"Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients.","volume":"29","author":"Pelosi","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"R8-6-20210212","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10350-004-0765-y","article-title":"Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography.","volume":"48","author":"Kobayashi","year":"2005","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"R9-6-20210212","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1055\/s-2004-814202","article-title":"Atypical endoscopic features of rectal carcinoids.","volume":"36","author":"Shim","year":"2004","journal-title":"Endoscopy"},{"issue":"3","key":"R10-6-20210212","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0720-048X(93)90071-T","article-title":"Rectal carcinoid tumor: endoscopic ultrasonographic detection and endoscopic removal.","volume":"16","author":"Fujishima","year":"1993","journal-title":"Eur J Radiol"},{"issue":"3","key":"R11-6-20210212","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.surg.2008.05.005","article-title":"A proposed staging system for rectal carcinoid tumors based on an analysis of 4701 patients.","volume":"144","author":"Landry","year":"2008","journal-title":"Surgery"},{"issue":"2","key":"R12-6-20210212","first-page":"231","article-title":"Carcinoids of the rectum. Review 207 refs.","volume":"179","author":"Mani","year":"1994","journal-title":"J Am Coll Surg"},{"issue":"4","key":"R13-6-20210212","first-page":"670","article-title":"Rectal carcinoid tumors-treatment and prognosis.","volume":"94","author":"Naunheim","year":"1983","journal-title":"Surgery"},{"issue":"2","key":"R14-6-20210212","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1245\/s10434-006-9197-3","article-title":"Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment.","volume":"14","author":"Fahy","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"R16-6-20210212","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. 37 refs.","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Archiv"},{"issue":"suppl 1","key":"R17-6-20210212","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051853","article-title":"Tumor markers in neuroendocrine tumors. Review 42 refs.","volume":"62","author":"Eriksson","year":"2000","journal-title":"Digestion"},{"issue":"18","key":"R18-6-20210212","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJM198605013141803","article-title":"Secretion of chromogranin A by peptide-producing endocrine neoplasms.","volume":"314","author":"O'Connor","year":"1986","journal-title":"New Engl J Med"},{"issue":"3","key":"R19-6-20210212","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2007-1004158","article-title":"Effectiveness of local endoscopic resection of rectal carcinoid tumors.","volume":"29","author":"Higaki","year":"1997","journal-title":"Endoscopy"},{"issue":"4","key":"R20-6-20210212","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0016-5107(99)70092-1","article-title":"\"Band-snare\" resection of small rectal carcinoid tumors.","volume":"50","author":"Berkelhammer","year":"1999","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"R21-6-20210212","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.gie.2005.08.002","article-title":"Successful outcomes of a novel endoscopic treatment for GI tumors: endoscopic submucosal dissection with a mixture of high-molecular-weight hyaluronic acid, glycerin, and sugar.","volume":"63","author":"Fujishiro","year":"2006","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"R22-6-20210212","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1067\/mge.2003.142","article-title":"Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device.","volume":"57","author":"Ono","year":"2003","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"R23-6-20210212","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-2004-814386","article-title":"Treatment of multiple rectal carcinoids by endoscopic mucosal resection using a device for esophageal variceal ligation.","volume":"36","author":"Okamoto","year":"2004","journal-title":"Endoscopy"},{"issue":"1","key":"R24-6-20210212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-2007-1024058","article-title":"Endoscopic resection of rectal carcinoid tumors using aspiration lumpectomy.","volume":"29","author":"Imada-Shirakata","year":"1997","journal-title":"Endoscopy"},{"issue":"6","key":"R25-6-20210212","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s002689900445","article-title":"Stage-dependent therapy of rectal carcinoid tumors.","volume":"22","author":"Schindl","year":"1998","journal-title":"World J Surg"},{"issue":"10","key":"R26-6-20210212","first-page":"677","article-title":"A system for a transanal endoscopic rectum operation. in German.","volume":"55","author":"Buess","year":"1984","journal-title":"Chirurg"},{"issue":"6","key":"R27-6-20210212","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s00464-006-9155-y","article-title":"Transanal endoscopic microsurgery in the treatment of rectal carcinoid tumor.","volume":"21","author":"Kinoshita","year":"2007","journal-title":"Surg Endosc"},{"issue":"1","key":"R28-6-20210212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/DCR.0b013e3181bbd6ee","article-title":"Transanal endoscopic microsurgery resection of rectal tumors: outcomes and recommendations.","volume":"53","author":"Tsai","year":"2010","journal-title":"Dis Colon Rectum"},{"issue":"11","key":"R29-6-20210212","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.","volume":"315","author":"Kvols","year":"1986","journal-title":"New Engl J Med"},{"issue":"6","key":"R30-6-20210212","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/annonc\/mdh216","article-title":"Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system.","volume":"15","author":"Oberg","year":"2004","journal-title":"Ann Oncol"},{"key":"R31-6-20210212","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.1999.17.2.600","article-title":"Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.","volume":"1917","author":"Rubin","year":"1999","journal-title":"J Clin Oncol"},{"issue":"3","key":"R32-6-20210212","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gut.38.3.430","article-title":"Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.","volume":"38","author":"Arnold","year":"1996","journal-title":"Gut"},{"issue":"11","key":"R33-6-20210212","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1111\/j.1572-0241.2000.03210.x","article-title":"The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors.","volume":"95","author":"Ducreux","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"28","key":"R35-6-20210212","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"R36-6-20210212","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1542-3565(05)00481-7","article-title":"Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial.","volume":"3","author":"Arnold","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R37-6-20210212","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/bjs.4149","article-title":"Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.","volume":"1990","author":"Kolby","year":"2003","journal-title":"Br J Surg"},{"issue":"11","key":"R38-6-20210212","first-page":"1297","article-title":"Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.","volume":"70","author":"Oberg","year":"1986","journal-title":"Cancer Treatment Reports"},{"issue":"11","key":"R39-6-20210212","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E","article-title":"Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.","volume":"83","author":"Eriksson","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"R40-6-20210212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00130404-200307000-00008","article-title":"Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.","volume":"9","author":"Gupta","year":"2003","journal-title":"Cancer J"},{"issue":"1","key":"R41-6-20210212","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/107327480601300110","article-title":"Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.","volume":"13","author":"Strosberg","year":"2006","journal-title":"Cancer Control"},{"issue":"6","key":"R42-6-20210212","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.surg.2003.07.025","article-title":"Aggressive surgery for metastatic liver neuroendocrine tumors.","volume":"134","author":"Norton","year":"2003","journal-title":"Surgery"},{"issue":"4","key":"R43-6-20210212","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/ASO.2006.03.071","article-title":"Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors. Erratum appears in Ann Surg Oncol. 2006;13(8):1162. Note: Strosberg, Jonathon corrected to Strosberg, Jonathan.","volume":"13","author":"Osborne","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"R44-6-20210212","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0002-9610(99)80107-X","article-title":"Hepatic resection for metastatic neuroendocrine carcinomas.","volume":"169","author":"Que","year":"1995","journal-title":"Am J Surg"},{"issue":"1","key":"R45-6-20210212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1055-3207(02)00076-5","article-title":"Hepatic surgery for metastases from neuroendocrine tumors.","volume":"12","author":"Sarmiento","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"R46-6-20210212","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.sla.0000164073.08093.5d","article-title":"Surgical treatment of advanced-stage carcinoid tumors: lessons learned.","volume":"241","author":"Boudreaux","year":"2005","journal-title":"Ann Surg"},{"issue":"12","key":"R47-6-20210212","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","article-title":"Radiolabeled somatostatin analog 177Lu-DOTA0,Tyr3octreotate in patients with endocrine gastroenteropancreatic tumors.","volume":"23","author":"Kwekkeboom","year":"2005","journal-title":"J Clin Oncol"},{"issue":"13","key":"R48-6-20210212","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","article-title":"Treatment with the radiolabeled somatostatin analog 177 Lu-DOTA 0,Tyr3octreotate: toxicity, efficacy, and survival.","volume":"26","author":"Kwekkeboom","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"R49-6-20210212","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.semnuclmed.2006.01.001","article-title":"Survival and response after peptide receptor radionuclide therapy with 90Y-DOTA0,Tyr3octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.","volume":"36","author":"Valkema","year":"2006","journal-title":"Seminars in Nuclear Medicine"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006676-201008000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:10:30Z","timestamp":1618035030000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201008000-00006"}},"subtitle":["Well-Differentiated NETs of the Distal Colon and Rectum"],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e3181ec1261","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}